SK Hynix Investor Shifts Entire Portfolio to Samchundang Pharma, Stock Plunges 29.92% Next Day

According to Financial News, a South Korean investor shifted their entire portfolio from SK Hynix to KOSDAQ-listed Samchundang Pharma on July 21, the day after forced liquidation of their margin trading position. The investor had posted on online community epumkorea on July 18 seeking to borrow funds to cover a margin call, with 140 million won in outstanding debt against 230 million won total in SK Hynix stock. Samchundang Pharma subsequently plunged 29.92%, closing at the lower limit of 167,500 won.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments